A Trial Investigating the Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in a Tablet Formulation With Three Different Coatings in Healthy Subjects
PHASE1
This trial is conducted in Europe. The aim of the trial is to investigate t...
Trial to Compare NNC0123-0000-0338 in a Tablet Formulation and Insulin Glargine in Subjects With Type 2 Diabetes Currently Treated With Oral Antidiabetic Therapy
PHASE2
This trial is conducted in Europe. The aim of this trial is to compare NNC0...
A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in Subjects With Type 2 Diabetes
PHASE1
This trial is conducted in Europe. The aim of the trial is to investigate t...